News
For the most up to date news, please follow us on LinkedIn via the link below
Download the White Paper describing how continuous aseptic freeze-drying can address the major pain points of pharmaceutical batch freeze-drying
We have created a White Paper describing how continuous aseptic freeze-drying can address the major pain points of pharmaceutical batch freeze-drying such as: time-consuming, inefficient, energy-consuming, and poorly controlled.
Download the White Paper on “Stabilizing mRNA LNPs via controlled, continuous freeze-drying”
Download the White Paper describing the advantages associated with a RheaVita’s NextGen continuous and controlled lyophilization.
Coriolis Pharma and RheaVita join forces in collaboration for continuous and controlled freeze-drying technology
Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients.
Continuous freeze-drying of mRNA LNPs enables storage at higher temperatures
Research at Ghent University, in collaboration with The University of British Columbia, has shown that continuous freeze-drying of mRNA LNPs enables long-term storage at higher temperatures for months without losing their transfection properties
Advanced Therapies – March 14 – 15, 2023
On March 14 & 15 we attended the Advanced Therapies Congress in London where we presented a new poster on avoiding cold chain logistic challenges by using freeze-drying to stabilize gene therapies.
